DBV TECHNOLOGIES financials
DBV TECHNOLOGIES
969500PVBQFWQKVDMD80 | Line item | 2025 | 2024 |
|---|---|---|
| Income statement | ||
| Other income | $5.6M | $4.2M |
| Operating expenses | $152.5M | $120.6M |
| Operating profit (EBIT) | -$146.9M | -$116.5M |
| Net finance income / (cost) | $246.0K | $2.4M |
| Finance costs | $2.6M | $1.5M |
| Income tax expense | $491.0K | $55.0K |
| Profit for the year | -$147.2M | -$114.1M |
| Total comprehensive income | -$140.2M | -$118.1M |
| Per share | ||
| Basic EPS | $-1.05 | $-1.18 |
| Diluted EPS | $-1.05 | $-1.18 |
| Cash flow statement | ||
| Net cash from operating activities | -$120.5M | -$103.2M |
| Net cash from investing activities | -$1.4M | -$760.0K |
| Net cash from financing activities | $275.5M | -$700.0K |
| Lease liability payments | $367.0K | $963.0K |
| Net change in cash | $153.6M | -$104.6M |
| Balance sheet | ||
| Total assets | $233.4M | $65.5M |
| Non-current assets | $20.5M | $21.2M |
| Property, plant & equipment | $10.4M | $11.3M |
| Right-of-use assets | $4.3M | $5.4M |
| Current assets | $212.9M | $44.4M |
| Cash & equivalents | $194.2M | $32.5M |
| Total equity | $168.8M | $27.4M |
| — attributable to owners | $168.8M | $27.4M |
| Non-current liabilities | $6.6M | $7.0M |
| Lease liabilities (non-current) | $5.4M | $6.3M |
| Current liabilities | $58.0M | $31.1M |
| Lease liabilities (current) | $1.1M | $654.0K |
| Derived metrics | ||
| Return on equity | -87.2% | -416.7% |
| Cash conversion ratio | 0.82× | 0.90× |
| Other reported items | ||
| Adjustments For Decrease Increase In Inventories | -$16.1M | $0 |
| Adjustments For Decrease Increase In Other Current Assets | -$4.7M | $4.6M |
| Adjustments For Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss Inventories | $16.1M | $0 |
| Adjustments For Increase Decrease In Other Liabilities | $6.0M | $366.0K |
| Adjustments For Increase Decrease In Trade Account Payable | $15.5M | $296.0K |
| Adjustments For Sharebased Payments | $5.4M | $4.6M |
| Cash Flows From Used In Operations Before Changes In Working Capital | -$121.2M | -$108.5M |
| Current Provisions | $217.0K | $122.0K |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | $8.1M | -$4.3M |
| Equity and Liabilities | $233.4M | $65.5M |
| Finance Income | $2.8M | $3.9M |
| General and Administrative Expense | $32.8M | $28.8M |
| Increase Decrease In Number of Shares Outstanding | 132.8M | 6.4M |
| Increase Decrease In Working Capital | -$783.0K | -$5.3M |
| Increase Decrease Through Appropriation of Retained Earnings | $0 | $0 |
| Increase Decrease Through Sharebased Payment Transactions | $5.4M | $4.6M |
| Increase Decrease Through Transfers and Other Changes Equity | $0 | -$35.0K |
| Increase Decrease Through Treasury Share Transactions | $476.0K | -$47.0K |
| Intangible Assets Other Than Goodwill | $22.0K | $40.0K |
| Issue of Equity | $205.7M | $635.0K |
| Issued Capital | $26.9M | $11.7M |
| Noncurrent Provisions | $1.2M | $722.0K |
| Number of Shares Outstanding | 235.7M | 102.8M |
| Other Adjustments For Noncash Items | $378.0K | $289.0K |
| Other Comprehensive Income | $7.0M | -$4.0M |
| Other Comprehensive Income Net of Tax Exchange Differences On Translation | -$46.0K | $16.0K |
| Other Comprehensive Income Net of Tax Exchange Differences On Translation Other Than Translation of Foreign Operations | $7.2M | -$4.2M |
| Other Comprehensive Income Net of Tax Gains Losses On Remeasurements of Defined Benefit Plans | -$197.0K | $228.0K |
| Other Noncurrent Assets | $5.8M | $4.4M |
| Research and Development Expense | $116.5M | $89.2M |
| Reserve of Exchange Differences On Translation | -$5.8M | -$13.0M |
| Retained Earnings Profit Loss For Reporting Period | -$147.2M | -$114.1M |
| Revenue and Operating Income | $5.6M | $4.2M |
| Selling Expense | $3.2M | $2.7M |
| Share Premium | $361.9M | $141.6M |
| Trade and Other Current Payables To Trade Suppliers | $40.9M | $22.0M |
Every line item above is a fact tagged in DBV TECHNOLOGIES's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (USD), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.